Davis SL - Search Results

1

Adjuvant chemotherapy of axillary node-negative carcinoma of the breast using doxorubicin and cyclophosphamide.

Brooks RJ, Jones SE, Salmon SE, Chase EM, Davis SL, Moon TE, Giordano GF, Ketchel SJ, Jackson RA. Brooks RJ, et al. Among authors: davis sl. NCI Monogr. 1986;(1):135-7. NCI Monogr. 1986. PMID: 3534586 Clinical Trial.

2

Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trial.

Jones SE, Salmon SE, Allen H, Giordano GF, Davis S, Chase E, Moon TE, Heusinkveld RS. Jones SE, et al. Recent Results Cancer Res. 1982;80:162-9. doi: 10.1007/978-3-642-81685-7_27. Recent Results Cancer Res. 1982. PMID: 7036279 Clinical Trial.

3

Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy.

Nash CH 3rd, Jones SE, Moon TE, Davis SL, Salmon SE. Nash CH 3rd, et al. Among authors: davis sl. Cancer. 1980 Dec 1;46(11):2380-8. doi: 10.1002/1097-0142(19801201)46:11<2380::aid-cncr2820461113>3.0.co;2-m. Cancer. 1980. PMID: 6449280

4

Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy.

Goodman GE, Miller TP, Manning MM, Davis SL, McMahon LJ. Goodman GE, et al. Among authors: davis sl. J Clin Oncol. 1983 Aug;1(8):483-8. doi: 10.1200/JCO.1983.1.8.483. J Clin Oncol. 1983. PMID: 6321685

5

Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials.

Davis S, Wright PW, Schulman SF, Hill LD, Pinkham RD, Johnson LP, Jones TW, Kellogg HB Jr, Radke HM, Sikkema WW, et al. Davis S, et al. Cancer. 1985 Oct 1;56(7):1710-8. doi: 10.1002/1097-0142(19851001)56:7<1710::aid-cncr2820560741>3.0.co;2-t. Cancer. 1985. PMID: 3896460 Clinical Trial.

6

Male breast carcinoma: clinical experience in a suburban community.

Davis SL, Barse F, Meoli FG. Davis SL, et al. J Am Osteopath Assoc. 1992 Aug;92(8):1005-6, 1013-6. J Am Osteopath Assoc. 1992. PMID: 1429059

7

Hodgkin's disease in the United States: a comparison of patient characteristics and survival in the Centralized Cancer Patient Data System and the Surveillance, Epidemiology, and End Results Program.

Davis S, Dahlberg S, Myers MH, Chen A, Steinhorn SC. Davis S, et al. J Natl Cancer Inst. 1987 Mar;78(3):471-8. J Natl Cancer Inst. 1987. PMID: 3469461

8

Long-term survival in small-cell carcinoma of the lung: a population experience.

Davis S, Wright PW, Schulman SF, Scholes D, Thorning D, Hammar S. Davis S, et al. J Clin Oncol. 1985 Jan;3(1):80-91. doi: 10.1200/JCO.1985.3.1.80. J Clin Oncol. 1985. PMID: 2981294

9

Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infection.

Arena CJ, Kenney RM, Ramesh M, Davis SL, Veve MP. Arena CJ, et al. Among authors: davis sl. Int J Infect Dis. 2025 Feb;151:107314. doi: 10.1016/j.ijid.2024.107314. Epub 2024 Nov 26. Int J Infect Dis. 2025. PMID: 39603409 Free article.

10

Engaging Student Members in Professional Nursing Research Organizations - Some Things for Our Organization to Consider.

Davis SL. Davis SL. Res Nurs Health. 2024 Dec;47(6):597-598. doi: 10.1002/nur.22426. Epub 2024 Nov 8. Res Nurs Health. 2024. PMID: 39513337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters